Travoprost
ApprovedCompleted 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Open-angle Glaucoma
Conditions
Open-angle Glaucoma
Trial Timeline
Sep 1, 2011 → Apr 1, 2017
NCT ID
NCT01443988About Travoprost
Travoprost is a approved stage product being developed by Glaukos for Open-angle Glaucoma. The current trial status is completed. This product is registered under clinical trial identifier NCT01443988. Target conditions include Open-angle Glaucoma.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04615403 | Phase 2 | Completed |
| NCT01443988 | Approved | Completed |
| NCT01444040 | Approved | Completed |
Competing Products
20 competing products in Open-angle Glaucoma